Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Catalyst Watch: Eyes on Jackson Hole, Target Earnings, and Canadian Rails Disruption
What 4 Analyst Ratings Have To Say About Bluebird Bio
Bluebird Bio Shares Are Trading Lower After JP Morgan Downgraded the Stock From Overweight to Neutral and Multiple Firms Lowered Their Respective Price Targets on the Stock.
10 Health Care Stocks With Whale Alerts In Today's Session
This Snowflake Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Bluebird Bio Analyst Ratings